Total Payments
$12,629
2022 Payments
$4,740
Companies
6
Transactions
42
Payment Breakdown by Category
Other$8,855 (70.1%)
Travel$2,744 (21.7%)
Food & Beverage$1,029 (8.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,855 | 9 | 70.1% |
| Travel and Lodging | $2,744 | 5 | 21.7% |
| Food and Beverage | $1,029 | 28 | 8.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $12,461 | 34 | $0 (2022) |
| Novo Nordisk Inc | $52.73 | 3 | $0 (2022) |
| GlaxoSmithKline, LLC. | $46.50 | 2 | $0 (2022) |
| Indivior Inc. | $26.58 | 1 | $0 (2021) |
| AbbVie Inc. | $22.05 | 1 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $19.65 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $4,740 | 11 | Gilead Sciences, Inc. ($4,704) |
| 2021 | $7,889 | 31 | Gilead Sciences, Inc. ($7,757) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/21/2022 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: VACCINES | ||||||
| 03/31/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Diabetes | ||||||
| 03/26/2022 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,040.00 | General |
| Category: HCV | ||||||
| 03/26/2022 | Gilead Sciences, Inc. | Epclusa (Drug) | Travel and Lodging | In-kind items and services | $822.21 | General |
| Category: HCV | ||||||
| 03/26/2022 | Gilead Sciences, Inc. | Epclusa (Drug) | Travel and Lodging | In-kind items and services | $350.00 | General |
| Category: HCV | ||||||
| 03/26/2022 | Gilead Sciences, Inc. | Epclusa (Drug) | Travel and Lodging | In-kind items and services | $336.58 | General |
| Category: HCV | ||||||
| 03/26/2022 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: HCV | ||||||
| 03/26/2022 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: HCV | ||||||
| 02/18/2022 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $930.00 | General |
| Category: HCV | ||||||
| 02/08/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $30.77 | General |
| 02/03/2022 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $94.50 | General |
| Category: HCV | ||||||
| 12/14/2021 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $930.00 | General |
| Category: HCV | ||||||
| 12/14/2021 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: OUD | ||||||
| 12/13/2021 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $94.50 | General |
| Category: HCV | ||||||
| 12/07/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $9.25 | General |
| 11/17/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.08 | General |
| 11/12/2021 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $930.00 | General |
| Category: HCV | ||||||
| 11/10/2021 | Gilead Sciences, Inc. | Epclusa (Drug) | Travel and Lodging | In-kind items and services | $567.49 | General |
| Category: HCV | ||||||
| 11/10/2021 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $97.49 | General |
| Category: HCV | ||||||
| 11/09/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $11.81 | General |
| 10/28/2021 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $930.00 | General |
| Category: HCV | ||||||
| 10/27/2021 | Gilead Sciences, Inc. | Epclusa (Drug) | Travel and Lodging | In-kind items and services | $667.82 | General |
| Category: HCV | ||||||
| 10/27/2021 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $69.80 | General |
| Category: HCV | ||||||
| 10/25/2021 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $285.00 | General |
| Category: HCV | ||||||
| 10/01/2021 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $930.00 | General |
| Category: HCV | ||||||
About Omeid Heidari, PHD, MSN, ANP-C
Omeid Heidari, PHD, MSN, ANP-C is a Family healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/06/2018. The National Provider Identifier (NPI) number assigned to this provider is 1942702915.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Omeid Heidari, PHD, MSN, ANP-C has received a total of $12,629 in payments from pharmaceutical and medical device companies, with $4,740 received in 2022. These payments were reported across 42 transactions from 6 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($8,855).
Ad
Practice Information
- Specialty Family
- Other Specialties Primary Care, Nurse Practitioner
- Location Seattle, WA
- Active Since 03/06/2018
- Last Updated 08/26/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1942702915
Products in Payments
- Epclusa (Drug) $12,241
- BEXSERO (Biological) $46.50
- Ozempic (Drug) $34.06
- SUBLOCADE (Drug) $26.58
- VRAYLAR (Drug) $22.05
- NEXPLANON (Drug) $19.65
- RYBELSUS (Drug) $18.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Seattle
Dr. Kevan Petterson, Dnp, Fnp, DNP, FNP
Family — Payments: $55,987
Family $55,987
Dr. Kaitlin Brasier, D.n.p., A.r.n.p., Rn, D.N.P., A.R.N.P., RN
Family — Payments: $27,842
Family $27,842
Ms. Karen Johnson, Arnp, ARNP
Family — Payments: $14,117
Family $14,117
Lilly Silva, Rn, Fnp, Msn, RN, FNP, MSN
Family — Payments: $9,101
Family $9,101
Amy Perez, Fnp, FNP
Family — Payments: $8,589
Family $8,589
Ms. Mei Kuen Erica To, Arnp, ARNP
Family — Payments: $7,418
Family $7,418